Modulation of CD28 and CD86 expression in patients with paracoccidioidomycosis in different periods of treatment

Scandinavian Journal of Immunology

Volumn 60, Issue 5, 2004, Pages 500-505

  Bozzi, A ^a   Reis, B S ^a   Prado, F L S ^a   Pedroso, E P ^a   Leite, M F ^a   Goes, A M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CYTOKINE RELEASE; HOST RESISTANCE; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; PARACOCCIDIOIDES BRASILIENSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SOUTH AMERICAN BLASTOMYCOSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD86; BIOLOGICAL MARKERS; CYTOKINES; HUMANS; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS;

EID: 8444246295     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01501.x     Document Type: Article

References (24)

1. Restrepo-Moreno A. Paracoccidioidomycosis. In: Juneann WM, Herman F, Mauro B, eds. Infections, Agents and Pathogenesis - Fungal Infections and Immune Responses. New York: CRC Press, 1993: 251-76.
2. Borges-Walmsley MI, Chen D, Shu X, Walmsley AR. The pathobiology of Paracoccidioides brasiliensis. Trends Microbiol 2002; 10:80-7.
3. Souto JT, Figueiredo F, Furlanetto A, Pfeffer K, Rossi MA, Silva JS. Interferon-γ and tumor necrosis factor-α determine resistance to Paracoccidioides brasiliensis infection in mice. Am J Pathol 2000;156:1811-20.
4. Neves J. Blastomicose Sul-americana (Paracoccidioidomicose). In: Patrus OA, Costa PU, Neves J, eds. Diagnostico E Tratamento das Doeçnas Infecciosas E Parasitárias. Rio de Janeiro: Guanabara Koogan, 1983:825-35.
5. Franco MVG, Goes AM, Koury MC. Model of in vitro granulomatous hypersensitivity in human paracoccidioidomycosis. Mycopathologia 1997;137:129-36.
6. Cano LE, Kashino SS, Arruda C et al. Protective role of gamma Interferon in experimental pulmonary paracoccidioidomycosis. Infect Immun 1998;66:800-6.
7. Calich VLG, Kashino SS. Cytokines produced by susceptible and resistant mice in the course of Paracoccidioides brasiliensis infection. Braz J Med Biol Res 1998;31:6l5-23.
8. Gonzalez A, De Gregori W, Velez D, Restrepo A, Cano LE. Nitric oxide participation in the fungicidal mechanism of gamma interferon-activated murine macrophages. Infect Immun 2000;68:2546-52.
9. Diniz SN, Cisalpino PS, Freire ATF et al. In vitro granuloma formation, NO production and cytokines profile from human mononuclear cells induced by fractionated antigens of Paracoccidioides brasiliensis. Hum Immunol 2001;62:799-808.
10. Oliveira SJ, Mamoni RL, Musatti CC, Papaiordanou PMO, Blotta MHSL. Cytokines and lymphocyte proliferation in juvenile and adult forms of paracoccidioidomycosis: comparisons with infected and non-infected controls. Microbes Infect 2002;4:139-44.
11. Peraçoli MTS, Kurokawa CS, Calvi SA et al. Production of pro- and anti-inflammatory cytokines by monocytes from patients with paracoccidioidomycosis. Microbes Infect 2003;5:4l3-8.
12. Arruda MS, Coelho KIR, Montenegro MR. Experimental paracoccidioidomycosis of hamster inoculated in the cheek pouch. Mycopathologia 1994;128:67-73.
13. Calich VLG, Singer-Vermes LM, Siqueira AM, Burger E. Susceptibility and resistance of inbred mice to Paracoccidioides brasiliensis. Br J Exp Pathol 1985;66:585.
14. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 1976;72:248-54.
15. Restrepo A, Jimenez BE. Growth of Paracoccidioides brasiliensis yeast phase in a chemically defined culture medium. J Clin Microbiol 1980;12:279.
16. Juvenale M, Del Negro GMB, Duarte AJS, Benard G. Antibody isotypes to a Paracoccidioides brasiliensis somatic antigen in sub-acute and chronic form paracoccidioidomycosis. Mycology 2001;20:127-34.
17. Del Negro GMB, Pereira CN, Andrade HF et al. Evaluation of tests for antibody response in the follow-up of patients with acute and chronic forms of paracoccidioidomycosis. J Med Microbiol 2000;49:37-46.
18. Kuchroo VK, Prabhu M, Brown JA. B7-1 and B7-2 costimulatory molecules active differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-18.
19. Ranger AM, Prabhu M, Kuchroo VK, Glimcher LH. B7-2 (CD86) is essential for the development of IL-4 producing T cells. Int Immunol 1996;8:1549-60.
20. Ferreira KS, Lopes JD, Almeida SR. Regulation of T helper cell differentiation in vivo by gp43 from Paracoccidioides brasiliensis provided by different antigen-presenting cells. Scand J Immunol 2003;58:290-7.
21. Cano LE, Singer-Vermes LM, Costa TA et al. Depletion of CD8(+) T cells in vivo impairs host defense of mice resistant and susceptible to pulmonary paracoccidioidomycosis. Infect Immun 2000;68:352-9.
22. Bava AJ, Mistchenko AS, Palacios MF et al. Lymphocyte subpopulations and cytokine production in paracoccidioidomycosis patients. Microbiol Immunol 1991;35:167-74.
23. Rudd CE, Schneider H. Unifying concepts in CD28, ICOS and CTLA-4 co-receptor signalling. Nat Rev Immunol 2003;3:544-56.
24. Campanelli AP, Martins GA, Souto TN et al. Fas-Fas ligand (CD95-CD95L) and cytotoxic T lymphocyte antigen-4 engagement mediate T cell unresponsiveness in patients with paracoccidioidomycosis. J Infect Dis 2003;187:1496-505.